Real-World Perspectives: Integrating EarliPoint Into Clinical Autism Assessment

In this episode of the EarliPoint Exchange, hosts Dr. Cheryl Tierney and Kirsten Yurich, BCBA, sit down with two leaders in autism diagnostics and care: Dr. Abigail Ley, MD, Medical Director of the Neurodevelopmental Conditions and Autism Program at Nicklaus Children’s Hospital, and Dr. Stephanie Luallin, PhD, HSPP, clinical psychologist at Lighthouse Autism Center.

Together, they discuss their firsthand experiences incorporating EarliPoint into clinical workflows, the practical impact it has had on evaluation processes, and how objective, eye‑tracking–based information complements traditional assessment techniques. Dr. Ley and Dr. Luallin share insights on how EarliPoint has influenced access to care, differential diagnosis discussions, and family engagement within their programs. This conversation explores the intersection of innovation and clinical reality, highlighting opportunities and challenges in making new tools work for providers, care teams, and the families they serve.

The webinar will be held on March 24, 2026, from 12:00 PM to 1:00 PM EST, and includes 1 BACB Learning CEU. Attendance is included free with a BehaviorLive subscription, and registrants will also have access to the recorded session on-demand for CEUs.

Learning Objectives

  • Describe how EarliPoint has been integrated into clinical diagnostic pathways within diverse practice settings, including hospital‑based neurodevelopmental programs and ABA‑linked diagnostic services.
  • Discuss the practical benefits and considerations of using objective, eye‑tracking–based assessment data alongside traditional behavioral evaluation methods.
  • Identify real‑world challenges and facilitators for adopting new autism diagnostic technologies in clinical practice to enhance access, efficiency, and family‑centered care.

Register now to reserve your spot and explore how to integrate EarliPoint into clinical autism assessment.

Latest News

See how EarliPoint fits seamlessly into your clinical workflow.

Jamie Pagliaro brings over two decades of leadership in autism and behavioral health to his role as President and CEO of EarliPoint. Most recently, he served as Chief Operating Officer at Rethink, a leading SaaS provider supporting individuals with autism and developmental disabilities. Under his leadership, Rethink’s behavioral health division became the company’s largest business unit, serving thousands of clinicians and driving scalable, tech-enabled care delivery.

Earlier in his career, Jamie was Executive Director of the New York Center for Autism Charter School, the first public charter school in New York State dedicated to children with autism. At EarliPoint, he leads the company’s mission to bring breakthrough science to the front lines of care—empowering providers, families, and health systems with earlier answers and better outcomes.

Jamie Pagliaro

President & Chief Executive Officer

Dr. Ami Klin is a globally recognized leader in autism research and early detection. As Director of the Marcus Autism Center and Division Chief of Autism and Developmental Disabilities at Emory University School of Medicine, he has dedicated his career to understanding how young children engage with the social world—and how subtle disruptions in attention can signal developmental differences. His pioneering work in eye-tracking science led to the development of EarliPoint™ Evaluation, the first FDA-authorized tool to objectively assess autism in children as young as 16 months.
At EarliPoint, Dr. Klin drives clinical strategy and innovation, ensuring that families and clinicians worldwide have access to timely, science-based insights that enable earlier, more personalized intervention. His career reflects a deep commitment to transforming how society supports children with autism—starting with the earliest signs.

Ami Klin, PhD

Chief Clinical Officer & Co‑Founder